Remove 2029 Remove Prospecting Remove Sales
article thumbnail

Guide to the AI Tools for Sales to Optimize Performance in 2023

Quantified

through 2029. Part of that growth comes from using AI tools for professional work, especially sales. According to Gartner, 75% of B2B sales organizations will augment traditional playbooks with AI by 2025 despite the current low adoption rate. Competitive pressure will drive companies to invest in AI tools for sales.

Sales 52
article thumbnail

Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3

pharmaphorum

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other interstitial lung diseases (ILDs). First approved back in 2014, it is still growing strongly, with its 2021 sales of €2.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Get Qualified B2B Telecom Sales Leads

Spotio

There’s never been a better time to be in telecom sales. billion in the US alone by 2029. In other words, there’s plenty of opportunity—as long as you know how to generate telecom sales leads effectively, of course. Building ICPs for your sales team will keep your reps focused. The result? Or lower prices.

Leads 52
article thumbnail

Intercept receives orphan drug designation for liver disease combo therapy

Pharmaceutical Technology

According to consensus forecasts from GlobalData’s Pharma Intelligence Centre, Ocaliva is forecasted to have global sales of $1.08 billion in 2029. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.